This is a Request For Information (RFI), which is announced as a prior information notice on
www.doffin.no via the electronic competition management tool CTM.
The tender competition which was the basis for the Norwegian Institute of Public Health’s current contract for Hexavalent vaccine was carried out in 2016. 2 tender offers were received, of which one was rejected due to significant conditions related to the time of the first delivery.
A market survey was held in spring 2018, and a decision was made to continue with the existing contract, (see point 2.2), but taking up the option for a third year.
The Public Health Institute would now like to get information again on the market situation for the Hexavalent vaccine, for delivery from 2020 onwards.
Feedback on this will be taken into consideration on whether to take up the last possible extension on the current contract, or whether to hold a new tender competition.